Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)

Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)

Related Resources

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Emerging Global Leader

Project Information in NIH RePORTER

Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)

Principal Institution

University of Ibadan College of Medicine

Principal Investigator(s) (PI)

Ntekim, Atara Isaiah

Project Contact Information

Email: kimata2000@hotmail.com

Year(s) Awarded

2018-2023

Country

Nigeria

NIH Partners

NCI

Related World Regions / Countries

Related Global Health Research Topics

  • Cancer